Skip to content
10-Q

Quarterly Report

DarioHealth Corp. DRIO

0001558370-25-007640

← back to feed
Filed
May 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 9, 2025 43.95M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $18.9M
Long Term Debt Q1 2025 · Dec 31, 2024 $23.47M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $27.85M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $27.76M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $34.37M
Current Liabilities Q1 2025 · Mar 31, 2025 $19.16M
Current Liabilities Q1 2025 · Dec 31, 2024 $16.64M
Current Assets Q1 2025 · Mar 31, 2025 $38.56M
Current Assets Q1 2025 · Dec 31, 2024 $40.53M
Total Assets Q1 2025 · Mar 31, 2025 $115.6M
Total Assets Q1 2025 · Dec 31, 2024 $118.88M
Shares Diluted Q1 2025 · Mar 31, 2024 34.44M sh
Capex Q1 2025 · Mar 31, 2024 $56K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$13.11M
Stockholders Equity Q1 2025 · Mar 31, 2024 $78.03M
Stockholders Equity Q1 2025 · Dec 31, 2023 $58.14M
Eps Diluted Q1 2025 · Mar 31, 2024 $0.20
Eps Basic Q1 2025 · Mar 31, 2024 $0.20
Sga Expense Q1 2025 · Mar 31, 2024 $6.74M
Rd Expense Q1 2025 · Mar 31, 2024 $6.64M
Net Income Q1 2025 · Mar 31, 2024 −$7.18M
Operating Income Q1 2025 · Mar 31, 2024 −$17.86M
Gross Profit Q1 2025 · Mar 31, 2024 $2.43M